Candel Therapeutics, Inc.
NASDAQCandel Therapeutics heads into its May 21 earnings print with a heavyweight short base, a stock up 72% over the past month, and a conflicted Street watching whether clinical momentum can justify a rally that bears clearly don't believe in. Short sellers have been steadily adding into the price strength. Short interest as a percentage of free float has climbed to 24%, up from about…
Snapshot as of 16 May 2026
Candel Therapeutics heads into its May 21 earnings print with a heavyweight short base, a stock up 72% over the past month, and a conflicted Street watching whether clinical momentum can justify a rally that bears…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CADL — free to start on ORTEX.
Sign up for free →Open CADL on ORTEX